Symptomatic Choledocholithiasis After Cholecystectomy
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Background
•

Clinical manifestations of choledocholithiasis include biliary colic, obstructive
jaundice, pancreatitis, and acute cholangitis

•

Secondary common bile duct (CBD) stones are common when the gallbladder is
intact or after recent cholecystectomy (CCY) whereas recurrent stones develop >3
years after surgery1,2

•

Patients with retained CBD stones after CCY may be asymptomatic for years and
there is limited data on their pattern of presentation

•

Despite known predisposing conditions and risk factors for recurrent biliary disease,
the role of intraoperative cholangiography (IOC) during CCY remains controversial

Results
Figure 2. Comparing clinical presentations of choledocholithiasis
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Figure 4. Comparing incidence and pattern of presentation in definite cases with or
without perioperative ERCP or IOC during CCY
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Aims
•
•

NO C C Y ( N= 261)

To compare incidence and pattern of presentation of symptomatic
choledocholithiasis in patients with and without prior CCY
To evaluate characteristics of and risk factors for recurrent biliary disease in postcholecystectomy patients

* 3 of the 258 patients with no CCY presented with concomitant biliary
pancreatitis and acute cholangitis

•

27.9% (100/358) of patients who presented with symptomatic choledocholithiasis
had a prior cholecystectomy

•

There was a disproportionate, statistically significant presentation of acute
cholangitis in post-cholecystectomy patients

Methods
•

•

Retrospective chart review of patients with choledocholithiasis presenting with
biliary colic, acute pancreatitis, or acute cholangitis at a secondary and tertiary care
center between January 2014 – December 2016

POST- C C Y ( N= 100)

•
•
•

Acute Cholangitis- p< 0.001
Biliary Colic- p= 0.008
Biliary Pancreatitis- p= 0.078

Figure 3. Demographic and clinical case data

The following patient data was collected: demographics, history, laboratory data,
imaging, and endoscopic retrograde cholangiopancreatography (ERCP) results

•

69.7% (23/33) of patients with symptomatic choledocholithiasis did not have
perioperative bile duct evaluation with prior CCY

•

Although the incidence of presentation within 3 years was 32.6% higher in patients
without IOC/ERCP during cholecystectomy, it was not statistically significant (p=
0.0536)

•

5 of 19 patients without perioperative ERCP/IOC presented with acute cholangitis
within 3 years of CCY

Figure 1. Flowchart of patient selection

Conclusions

Adults with DRG code for
choledocholithiasis and ERCP for the
same admission, 2014-2016; n=736
Exclusion by patient history: previous
biliary stents, bile duct surgery, partial
cholecystectomy (cystic duct remnant),
primary sclerosing cholangitis, or
expired during study period; n=68
Reviewed imaging and ERCP findings; n=668
Exclusion by: biliary obstruction not due to
stones (strictures, extrinsic compression), or
concomitant stones on presentation, or the
absence of stone collection or recent passage
on imaging; n=310

*Only representative of patients with confirmed procedure dates (n=30)

History of CCY; n=100

Recurrent biliary obstruction due to post-CCY choledocholithiasis is not uncommon

•

The disproportionate prevalence of acute cholangitis in post-CCY patients is
multifactorial

•

Limitations include: data collection capturing only patients with complications, lack
of confirmed procedure dates and perioperative ductal evaluation in all patients, and
skewed pattern of presentation given tertiary referral center

•

Given the frequency of gallstone-related disease recurrence within 3 years after CCY,
the absence of significant risk factors, and the lack of definitive cholestasis on
laboratory data and imaging, the role of intraoperative cholangiography should be reevaluated in future studies

•

Consider a prospective study on recurrent biliary disease post-CCY to determine a
cost-effective analysis and risk-benefit ratio of routine IOC

•

No significant difference in sex, race, age, BMI, or presence of periampullary
diverticulum

•

Few post-cholecystectomy patients had clinical conditions associated with formation
of sludge or microlithiasis

•

Some patients did not have laboratory data or a wide common bile duct to suggest
cholestasis due to CBD stones
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